PTEN promoter methylation and protein expression in normal early placentas and hydatidiform moles

被引:21
作者
Chen, HZ [1 ]
Ye, DF [1 ]
Xie, X [1 ]
Lu, WG [1 ]
Zhu, CK [1 ]
Chen, XD [1 ]
机构
[1] Zhejiang Univ, Dept Oncol, Womens Hosp, Sch Med, Hangzhou 310006, Peoples R China
关键词
trophoblasts; gestational trophoblastic disease; PTEN; promoter methylation;
D O I
10.1016/j.jsgi.2005.01.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To investigate the relationship between PTEN promoter methylation and protein expression, and the possible involvement of the PTEN gene in development of gestational trophoblasts and the pathogenesis of hydatidiform moles. METHODS: DNA was extracted from choria of normal early placentas, partial hydatidiform moles, complete hydatidiform moles, and invasive moles, and overdigested by methylation-sensitive endonucleases HpaII. The PTEN promoter was amplificated by polymerase chain reaction. PTEN protein expression was detected by immunohistochemistry. RESULTS: In partial and complete hydatidiform moles, the PTEN promoter methylation rate was significantly higher than in early placentas (72%, 59.4%, 14.3%; P = .000, .002, respectively), and the PTEN protein expression rate was significantly lower than in early placentas (9.1%, 4.5%, 90.5%; P =. 000,. 000, respectively). However, partial hydatidiform moles, complete hydatidiform moles, and invasive moles were not significant different in terms of PTEN promoter methylation and protein expression. CONCLUSIONS: These findings suggest that the regulation of PTEN expression may play an important role in the development of the early gestational trophoblast and in the pathogenesis of hydatidiform mole, but not in its malignant tran. formation. Copyright (c) 2005 by the Society for Gynecologic Investigation.
引用
收藏
页码:214 / 217
页数:4
相关论文
共 26 条
  • [11] COMPLETION OF MOUSE EMBRYOGENESIS REQUIRES BOTH THE MATERNAL AND PATERNAL GENOMES
    MCGRATH, J
    SOLTER, D
    [J]. CELL, 1984, 37 (01) : 179 - 183
  • [12] P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
    Myers, MP
    Stolarov, JP
    Eng, C
    Li, J
    Wang, SI
    Wigler, MH
    Parsons, R
    Tonks, NK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) : 9052 - 9057
  • [13] Nadav L, 2001, INT J ONCOL, V19, P237
  • [14] PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein
    Paramio, JM
    Navarro, M
    Segrelles, C
    Gómez-Casero, E
    Jorcano, JL
    [J]. ONCOGENE, 1999, 18 (52) : 7462 - 7468
  • [15] PERSAUD V, 1993, W INDIAN MED J, V42, P142
  • [16] Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of Iκ-B-α that can be inhibited by the tumor suppressor PTEN
    Pianetti, S
    Arsura, M
    Romieu-Mourez, R
    Coffey, RJ
    Sonenshein, GE
    [J]. ONCOGENE, 2001, 20 (11) : 1287 - 1299
  • [17] Salvesen HB, 2001, INT J CANCER, V91, P22, DOI 10.1002/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO
  • [18] 2-S
  • [19] Regulation of PTEN transcription by p53
    Stambolic, V
    MacPherson, D
    Sas, D
    Lin, Y
    Snow, B
    Jang, Y
    Benchimol, S
    Mak, TW
    [J]. MOLECULAR CELL, 2001, 8 (02) : 317 - 325
  • [20] LOSS OF IMPRINTING OF IGF2 IS LINKED TO REDUCED EXPRESSION AND ABNORMAL METHYLATION OF H19 IN WILMS-TUMOR
    STEENMAN, MJC
    RAINIER, S
    DOBRY, CJ
    GRUNDY, P
    HORON, IL
    FEINBERG, AP
    [J]. NATURE GENETICS, 1994, 7 (03) : 433 - 439